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RESOURCE ARTICLE
A simple method for in vivo labelling of infiltrating leukocytes in the
mouse retina using indocyanine green dye
Dawn A. Sim1,2, Colin J. Chu2,3, Senthil Selvam1,2, Michael B. Powner2, Sidath Liyanage2, David A. Copland3,
Pearse A. Keane1,2, Adnan Tufail1,2, Catherine A. Egan1, James W. B. Bainbridge1,2, Richard W. Lee1,3,
Andrew D. Dick1,3 and Marcus Fruttiger2,*
ABSTRACT
We have developed a method to label and image myeloid cells
infiltrating the mouse retina and choroid in vivo, using a single depot
injection of indocyanine green dye (ICG). This was demonstrated
using the following ocular models of inflammation and angiogenesis:
endotoxin-induced uveitis, experimental autoimmune uveoretinitis
and laser-induced choroidal neovascularization model. A near-
infrared scanning ophthalmoscope was used for in vivo imaging of
the eye, and flow cytometry was used on blood and spleen to assess
the number and phenotype of labelled cells. ICG was administered
72 h before the induction of inflammation to ensure clearance from
the systemic circulation. We found that in vivo intravenous
administration failed to label any leukocytes, whereas depot
injection, either intraperitoneal or subcutaneous, was successful in
labelling leukocytes infiltrating into the retina. Progression of
inflammation in the retina could be traced over a period of 14 days
following a single depot injection of ICG. Additionally, bright-field
microscopy, spectrophotometry and flow cytometric analysis suggest
that the predominant population of cells stained by ICG are circulating
myeloid cells. The translation of this approach into clinical practice
would enable visualization of immune cells in situ. This will not only
provide a greater understanding of pathogenesis, monitoring and
assessment of therapy in many human ocular diseases but might
also open the ability to image immunity live for neurodegenerative
disorders, cardiovascular disease and systemic immune-mediated
disorders.
KEY WORDS: Indocyanine green, Inflammation, In vivo imaging
INTRODUCTION
Resident and infiltrating leukocytes have an important role in sight-
threatening diseases of the eye. Substantial evidence exists to
confirm not only that activation and altered immune responses
happen in uveitic syndromes (Lee et al., 2014) but that they may also
occur in the form of parainflammation (Xu et al., 2009) and initiate
or exacerbate age-related macular degeneration and diabetic
retinopathy (Whitcup et al., 2013). Here, the cellular participants
of the immune system act as drivers for pathological angiogenesis,
forming the two main causes of blindness in Western industrialized
countries, namely, age-related macular degeneration and diabetic
retinopathy (Penfold et al., 1987; Lopez et al., 1991; Lutty et al.,
1997; Joussen et al., 2001). A better understanding of the role of
inflammation in the development of pathological angiogenesis is
essential for the development of disease-modifying strategies not
only for monitoring disease progression but also to assess the
efficacy of treatments.
The development of clinically viable imaging tools for in vivo
visualization of inflammation is a crucial step in this process. To
date, live imaging of inflammation has been restricted to
experimental animal models, with examples such as magnetic
particles (iron oxide and gadolinium chelates) for magnetic
resonance imaging, fluorescent nanoparticles which can be tagged
with aptamers or peptides targeted against cell surface biomarkers,
circulating factors or nucleic acid structures, or dyes such as acridine
orange, which is a known human carcinogen (Joussen et al., 2001;
Rausch et al., 2001; Montet-Abou et al., 2010; Roivainen et al.,
2012; Cibiel et al., 2012; Nahrendorf et al., 2007; Hossain et al.,
1998). The only application that is currently used to image
inflammatory cells in humans is based on in vitro radionucleotide
labelling of leukocytes from the patient’s own blood. Although this
allows direct visualization of cell migration patterns, current
imaging techniques do not allow sufficient resolution to track
single cells (van Hemert et al., 2007).
Here, we present the use of indocyanine green (ICG) for in vivo
visualization of myeloid cells in the mouse. ICG is a near-infrared
(NIR) fluorescence tricarbocyanine dye with a peak spectral
absorption of 800-810 nm (in blood) that is approved by the US
Food and Drug Administration for clinical use. The introduction
of ICG in ophthalmic angiography in the late 1960s was largely
because of its minimal toxicity and favourable optical and
biophysical properties (Kogure et al., 1970). NIR light could
penetrate the ocular pigments of the eye, such as melanin and
xanthophyll, thereby allowing visualization of the deep choroidal
vasculature (not possible with conventional fluorescein
angiography). In addition, its tendency for conjugation to plasma
proteins meant that the dye did not readily leak from the fenestrated
choriocapillaris (Cherrick et al., 1960).
Despite thewide use of intravenous (i.v.) ICG, US Food and Drug
Administration approval and a good safety profile, there is limited
evidence for its use in cellular imaging. This is probably because of
its pharmacokinetic properties; ICG is rapidly removed from the
circulation via hepatic clearance and it has a half-life of
approximately 3-4 min, which precludes in vivo labelling of cells.
However, we observed that by administering ICG as a depot
injection, we could obtain reproducible labelling of peripheral
CD11b+ circulating myeloid cells, establishing a novel method for
in vivo tracking of these cells at near single-cell resolution as theyReceived 9 January 2015; Accepted 9 August 2015
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invade the eye in response to inflammation and injury. Furthermore,
we found in vitro evidence that human myeloid cells stain in a
similar manner, which strongly supports the translation of this
promising technique into clinical practice.
RESULTS
In vitro labelling of peripheral blood mononuclear cells
(PBMCs) and splenocytes with ICG
To establish whether ICG can label circulating leukocytes, we
incubated whole blood with the dye in vitro for 30 min at room
temperature. Visual inspection of a blood smear from human blood
by fluorescent microscopy revealed a small population of
fluorescent cells in the NIR channel (Fig. 1A,B). Next, we
exposed PBMCs isolated from human and mouse blood, and
mouse splenocytes to ICG (30 min at room temperature) and then
analysed dye uptake and cell identity by flow cytometry. In human
PBMCs, whilst all cells stained slightly with the dye, around 2-5%
of all cells were strongly stained with ICG (Fig. 1C,D). In mouse
PBMCs, <1% of all cells were strongly stained with ICG (Fig. 1E,F)
compared with 7-10% of mouse splenocytes, which consist of both
splenic reservoir monocytes and resident macrophages (Fig. 1G,H).
We observed that although the proportion of ICG-stained cells
increased when incubated at higher temperatures and in higher
concentrations of ICG, therewas an increase in non-specific staining.
Furthermore, the staining of cells varied with the number of washes
and volume of media used. We identified that a 30 min incubation of
ICG at a concentration of 6.25 µg/ml at room temperature, with two
washes in 5 ml PBS, achieved reproducible staining of cells.
Furthermore, we identified that the minimal dose at which stained
cells could be detectedwas 1.5 µg/ml, although 5 µg/ml was required
for reliable and reproducible staining. In vitro, the specificity of ICG
binding to PBMCs was dependent upon the concentration, ambient
temperature and period of incubation (data not shown).
Assessment of the efficiency of ICG cell labelling and its
effects on macrophages and lymphocytes
To assess the efficiency of ICG uptake of different populations of
cells, we used cultured mouse bone-marrow-derived macrophages
(BMDMs) and magnetic-activated cell sorted CD4+ mouse
lymphocytes from the spleen. We observed, using flow
cytometry, that whilst both populations were stained with ICG,
BMDMs were more strongly stained than CD4+ cells (Fig. 2A). A
2 h exposure of BMDMs to ICG (200 ng/ml) led to a green stain of
BMDMs that was visible in bright-field microscopy (Fig. 2B). The
uptake of ICG in BMDMs was not affected by activation of the cells
with lipopolysaccharide (LPS; Fig. 2C,D). Conversely, ICG did not
activate BMDMs, as assessed by interleukin-6 (IL-6) production
(Fig. 2E). In order to assess whether ICG was internalized by the
cells or whether it only stained the cell membrane, we measured
ICG release of stained cells after lysis by spectrophotometry.
Increasing absorption at 790 nm suggested the release of
internalized dye (Fig. 2F).
In vivo labelling of infiltrating leukocytes by ICG
First, we examined whether ICG labelling was possible in vivo, and
second, whether these labelled cells could also be imaged in vivo.
To this end, we administered 1 mg of ICG by intraperitoneal (i.p.)
injection to C57BL/6 mice 3 days before they were imaged in three
disease models in which there is substantial leukocytic (including
monocyte/macrophage) retinal infiltration.
The first model was endotoxin-induced uveitis induced by
systemic delivery of LPS from Escherichia coli. A previous study
detected Acridine Orange-labelled leukocytes in the subretinal
space/deep retina, 2 days after LPS injection (Miyahara et al., 2004).
We found that ICG-labelled cells were detectable in the retina
in vivo using fluorescence scanning laser ophthalmoscopy, 24 h
after LPS injection, with a peak at 2 days after LPS administration
(and 5 days after i.p. ICG; Fig. 3A). No signal was seen in the
fluorescein channel (488 nm solid-state excitation laser and 500 nm
barrier filter), indicating that the ICG signal did not derive from
autofluorescence (Fig. 3B). Control animals that were injected only
with ICG but not with LPS showed only a few sporadic ICG+ cells
(Fig. 3C,D). This suggests low levels of peripheral cell trafficking in
the normal retina, as previously inferred via flow cytometric
analysis (Boldison et al., 2014; Chu et al., 2013), which
dramatically increases after LPS stimulation.
The second model was experimental autoimmune uveoretinitis,
an antigen-dependent CD4+ T-cell-initiated ocular autoimmune
disease, which shares features with human uveitis. Unlike the
endotoxin-induced uveitis model, which produces a diffuse, short-
lived inflammation in the deep retina and choroid, the prominent
features of the experimental autoimmune uveoretinitis model
include marked infiltration of myeloid and T-cells around inner
retinal blood vessels (vasculitis) and a more sustained inflammation
with retinal infiltration and damage and remodelling developing
over many weeks (Dick et al., 1996). We found that 26 days after
immunization of these animals, ICG-labelled cells could be
visualized in the retina, choroid and particularly in areas of active
vasculitis (Fig. 3E,F), correlating with published histology of
activated myeloid cells in this model (Dick et al., 1995).
TRANSLATIONAL IMPACT
Clinical issue
Inflammation underpins most of the pathological consequences of
human disease. Until now, measurement of inflammation has been
confined to surrogate markers, such as the size of a lesion, its
appearance, or the levels of inflammatory mediators in the blood.
Resident and infiltrating leukocytes are important players in eye
diseases, and a better understanding of their role in these conditions is
essential not only for monitoring disease progression but also to assess
the efficacy of treatments. The development of clinically viable imaging
tools for in vivo visualization of inflammation is a crucial step in this
process, but current imaging techniques do not allow sufficient resolution
to track single cells.
Results
In this work, the authors describe a simple method by which cellular
effectors of inflammation – namely, white-blood cells – can be visualized,
measured, and monitored over time in the mouse retina. They use a
single depot injection of indocyanine green (a dye that has been used
safely in humans for blood flowmeasurements for more than 60 years) to
label inflammatory cells in the periphery. This allowed them to track the
invasion of those cells into the retina in eye disease models. Retinal
infiltration of inflammatory cells was detected in mice in three models of
retinal inflammation and angiogenesis, after a single depot injection of
indocyanine green dye. Cells could bemonitored in the retina for a period
of 14 days, and the large majority were identified as infiltrating lymphatic
and myeloid cells.
Implications and future directions
If translated successfully into humans, this method will allow direct
monitoring of inflammation and assessment of treatment strategies in a
variety of diseases, including not only human ocular diseases but also
neurodegenerative disorders, cardiovascular diseases and systemic
immune-mediated disorders.
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The third model was the laser-induced choroidal
neovascularization (CNV) model, a model widely used to study
pathological angiogenesis in the retina (Montezuma et al., 2009).
The vascular response in this model is accompanied by an
accumulation of infiltrating leukocytes in the laser lesion from the
circulation and from within the retina (Horie et al., 2013; Liu et al.,
2013). We hypothesized that the infiltrating leukocytes can be
visualized by labelling cells with ICG in the periphery. Given that
laser injury can induce autofluorescence, we first imaged animals
without ICG. In the NIR channel, no fluorescence was detected in
the lesion (Fig. 4A). Next, we tested whether administration (i.p.) of
ICG immediately after the laser would result in ICG leakage into the
retina. Although ICG could be visualized in the retinal vasculature
and laser lesions, overt leakage of ICG into the retina was not
apparent (Fig. 4B). As before, in order to ensure that there was
sufficient time for ICG labelling of cells in the circulation and the
clearance of ICG from the circulation, we injected ICG 3 days
before laser induction of CNV. Given that ICG is rapidly cleared
from the circulation, we reasoned that a 3-day delay would be
sufficient to minimize any ICG in the circulation that might leak
directly into the retina from the bloodstream and label resident
retinal macrophages. Consistent with this, ICG could no longer be
detected in the circulation by NIR imaging at this stage (not shown).
Seven days after induction of the laser lesion (10 days after ICG), we
observed a marked aggregation of clearly labelled cells in and
around the laser lesions (Fig. 4C,C′). After a further 3 days (10 days
after laser), the signal started to subside (Fig. 4D,D′). ICG+ cells
were observed in laser lesions that developed CNV and also in those
that had no fluorescein angiographic evidence of CNV after 7 days.
This is illustrated by an example shown in Fig. 4E. Here, six laser
Fig. 1. In vitro labelling of peripheral blood
mononuclear cells (PBMCs) and splenocytes in
humans and mice. (A,B) Blood smear of human
blood incubated in a concentration of 6.25 µg/ml
indocyanine green dye (ICG) for 30 min at room
temperature. A small proportion of cells stained
with ICG were visualized on the near-infrared
channel at 10× magnification (A) and 20×
magnification (B). (C,D) Detection of ICG-stained
human PBMCs by flow cytometry in cells incubated
in PBS and 6.25 µg/ml of ICG reveals that 4.9% of
all cells were labelled and, of these, 4.4% were
CD45-high. (E,F) In mouse PBMCs, although ICG
labelling was also observed in the same in vitro
conditions, a smaller proportion of ICG-labelled
cells were detected; 0.8% of total cells.
(G,H) Mouse splenocytes were more readily
labelled with ICG, with 9.5% of total cells staining
with ICG.
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lesions were applied. Although all of them accumulated ICG+ cells
(Fig. 4E), only two lesions showed signs of neovascularization
based on fluorescein angiography (Fig. 4F,G).
Furthermore, dissection of the mice 7 days after administration of
ICG i.p. revealed green staining of lymphatic tissue in the thoracic
cavity (Fig. S1A,B), mediastinal lymph nodes (Fig. S1C), thymus
(not shown) and the greater omentum in the abdominal cavity
(Fig. S1D-F). This suggests that inflammatory cells in the
circulation, most probably both monocytes and lymphocytes that
continuously circulate between the bloodstream and lymphoid
organs, are labelled by the ICG. To check whether ICG might be
toxic to the cells that take it up, we used flow cytometry to measure
cell death in inflammatory cells that had been stained in vitro (after
30 min) and in vivo (10 days after ICG injection) in the CNVmodel.
This showed no noticeable differences in cell counts, indicating that
ICG has no gross effects on inflammatory cell populations in the
spleen, the retina and the choroid (Fig. S2) within the time frame of
our experiments (10 days).
We next tested whether cellular infiltration around the laser-
induced CNV lesion could be monitored over time. As before, ICG
was administered i.p. 3 days before the laser, and animals were
imaged sequentially 2, 5 and 8 days after laser CNV induction
(Fig. 5). The number of ICG-labelled cells in and surrounding the
CNV lesion could be observed qualitatively to increase over time
(Fig. 5C-E). Next, we assessed the feasibility with which this could
be quantified reproducibly. First, we attempted a simple pixel count
by thresholding individual CNV lesions (Fig. S3); a method we
have used successfully for quantifying ICG-labelled cells in
endotoxin-induced uveitis models (data not shown). However,
because of the narrow range of intensity values within each lesion, it
was not possible to visualize individual cells overlying the CNV
lesion. Nonetheless, we found that by assessing the mean intensity
values for a given pixel area using histograms, we were able to
quantify cellular infiltration over CNV lesions (Fig. S3G). Using
this method, we demonstrated that ICG-labelled cellular infiltration
can be quantified and monitored over time (Fig. 5B,C′-E′).
Given that ICG is routinely used in clinical practice, we compared
the dosage and delivery routes normally used in humans (5 mg i.v.
bolus injection) with our mouse protocol (1 mg i.p. bolus injection).
We reduced the ICG in a stepwise fashion from 1 mg to 0.0125 mg,
which roughly equates to the human dose in ophthalmic use.
Invading cells could still be detected readily after administration
of 0.5 mg ICG i.p., but at 0.25 mg they were fainter. With
progressively reduced amounts of ICG (0.125, 0.05, 0.025 and
0.0125 mg), the lesions were faintly fluorescent, but individual cells
could no longer be detected (Fig. S4). Out of the different delivery
routes tested, i.p. was the most efficient at labelling cells.
A subcutaneous depot (1 mg) produced weaker labelling, but
individual cells could still be detected, whereas i.v. (1 mg) delivery
produced only very faint staining. In addition, i.v. delivery of ICG
shortly before the laser produced only staining of the retinal and
choroidal vasculature, with diffuse leakage of ICG into the laser-
induced CNV lesion, and individual cells could not be detected (not
shown). Oral administration (by gavage or in drinking water) did not
lead to any labelling (Fig. S5).
Characterization of in vivo ICG-labelled cells
To test the identity of ICG+ cells invading the retina in the laser-
induced CNV model, we used an in vivo staining protocol. After
ICG imaging (Fig. 6A-C), a fluorescently labelled (fluorescein
isothiocyanate) antibody against CD11b was injected. Over the
course of 30 min, this labelled a population of cells that matched the
Fig. 2. ICG labels macrophages by internalization of the dye but does not appear to cause activation. (A) In vitro-labelled bone-marrow-derived
macrophages (BMDMs, red) appear in flow cytometry more strongly labelled than CD4+ lymphocytes (blue; unlabelled cells are indicated by stippled lines).
(B) Bright-field microscopy of BMDMs cultured for 2 h with 0.2 mg/ml ICG identifies regions of visible green dye apparently within cells. (C,D) Applying LPS,
5 ng/ml LPS only (C) and LPS+ICG (D) did not lead to a marked difference in ICG uptake. (E) There is no evidence of classical activation, as measured by the
production of interleukin-6 (IL-6) from supernatants taken at different time points. Data were combined from two separate experiments (means+s.d. are shown).
(F) BMDMs were incubated with 0.2 mg/ml ICG. Following several washes, PBS was incubated with the cells for 5 min, then tested by spectrophotometry and
compared with supernatants from the same cells after lysis with 2% Triton. Increasing the duration of ICG incubation led to increased absorption, consistent
with the release of progressive internalized ICG.
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ICG-labelled cells spatially (Fig. 6D-F). The CD11b signal was
weaker than the ICG signal and there was not a perfect overlap.
Nevertheless, all CD11b-positive cells were also ICG positive. The
same approach was also taken with an anti-CD45 antibody, with the
same outcome (data not shown). This suggests the identity of most
of the ICG-labelled cells in the retina to be infiltrating myeloid cells.
DISCUSSION
We describe here a novel technique for in vivo labelling of a
subpopulation of circulating cells with ICG dye. We found that
in order to label these cells reproducibly in vivo, ICG must be
administered as a depot preparation. Using this approach, we
showed in three disease models of retinal inflammation that
infiltrating leukocytes can be detected, tracked over time and
quantified in the murine retina.
We found that the commonly used i.v. route of administration
of ICG failed to label infiltrating leukocytes. However, by
administering ICG as a depot, we have shown that infiltrating
cells were clearly labelled in our disease models. A possible
explanation for this is the increase in the period of ICG exposure that
circulating cells have, in order to be labelled. In keeping with this,
we observed in vitro that an increased time of exposure to ICG
resulted in increased cell labelling. Furthermore, we observed both
in vivo and in vitro that the majority of labelled cells were of myeloid
origin.
Our technique will be useful in the above-mentioned mouse
models. In particular, the laser-induced neovascularization model
is widely used to study pathological vessel growth in the retina.
This model also contains an important inflammatory component,
which has so far been assessed mainly by immunohistochemistry
on postmortem tissue. With our ICG technique, it will be
possible to monitor inflammatory cell invasion longitudinally in
these animals.
More generally, in the field of inflammation, the ability to
monitor a sequence of events over time is particularly important in
order to establish cause-and-effect relationships. As such, recent
developments have been focused on the ability to visualize
inflammation in vivo using molecular imaging techniques, such as
intravital microscopy using fluorescent antibodies, nanoparticles
and transgenic animals that express fluorescent proteins (Miyahara
et al., 2004; Shen et al., 2007). One study has used intravitreal
ICG in murine CNV models (Paques et al., 2010). The vitreous
cavity acts as a reservoir, thereby allowing prolonged exposure of
cells to ICG (similar to that of a depot application). Intravitreal
ICG was observed to label microglial cells for up to several
weeks, allowing time-lapse observation of migratory behaviour
after injury. In a similar fashion, our ICG method labels peripheral
circulating cells but avoids potential neurotoxic effects of
prolonged exposure of ICG to the retina, as observed by
vitreoretinal surgeons who use ICG as a vital stain to visualize
the internal limiting membrane during macular hole surgery
(Stanescu-Segall and Jackson, 2009). Although depot ICG does
not target specific cell types or epitopes like transgenic animals or
antibodies, nor have we identified the identities or proportion of
infiltrating cells stained, it has the advantage of having a simple
application technique (depot injection), does not depend on
specific mouse strains and, most importantly, has the potential for
rapid translation to human use.
Current strategies for in vivo molecular imaging in humans
include conjugation of NIR dyes, such as ICG, with ligands such
as small molecules, antibodies, peptides, DNA and nanoparticles.
Nevertheless, none of these probes has been approved for
human use because of their so far insufficiently characterized
safety profiles. In particular, nanoparticles suffer from poorly
characterized distribution, accumulation and clearance from the
Fig. 3. In vivo labelling of infiltrating leukocytes in two murine models of
ocular inflammation. (A) Inflammatory infiltration of the deep retina/choroid of an
eye with endotoxin-induced uveitis, imaged using a scanning laser
ophthalmoscopewith anear-infrared filter (790-nmdiodeexcitation laserand800-
nm long-pass filter). ICG-labelled cells were visualized as white dots throughout
the 55° field of view after an intraperitoneal (i.p.) injection of ICG (5 days before
imaging) and induction of systemic inflammation with an i.p. injection of
lipopolysaccharide (2 days before imaging). (B) An image of the deep retina/
choroid of the same mouse was taken in the fluorescein angiography (AF)
channel, using a blue-light filter (488-nm solid-state excitation laser and 500-nm
long-pass filter). Nowhite dots are present, demonstrating that white dots imaged
in A are not a consequence of autofluorescence but ICG-labelled cells. (C) A
control mouse that only received i.p. ICG (3 days before imaging). Imaging with a
near-infrared filter showed only a few sporadic ICG-labelled cells, suggesting a
low-level circulationofmyeloidcells into the retina. (D)An imageof thedeep retina/
choroid of the same mouse was obtained using the 488-nm channel, illustrating
that the identified cellswerenot autofluorescent in this range. (E) Inflammationof a
retinal vein (vasculitis) is visualized using the near-infrared filter in an eye at peak
experimental autoimmune uveitis. ICG-labelled cells were visualized as white
dots clustering around a segment of vasculitis. Mice with experimental
autoimmune uveitis received an injection of i.p. ICG 3 days before imaging peak
disease on day 26. (F) An infrared-reflectance (IR) image (820-diode excitation
laser, no barrier filter) of the samemousewas obtained, which demonstrates the
segment of retinal vein affected by vasculitis with increased reflectance (higher
white intensity) of the vein itself, and surrounding tissues. Of note, no white dots
were observed in this image, indicating that again, the white dots observed in
(C) are not the result of autofluorescence but of ICG-labelled cells.
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human body, and potential cytotoxicity of heavy metal
ingredients (Nel et al., 2006; Mancini et al., 2008). In contrast,
ICG is an inert, water-soluble organic dye that is rapidly bound to
plasma proteins and solely removed from the circulation through
the liver via a specific carrier-mediated transport system (Donald
and Yipintsoi, 1973). Furthermore, ICG is known not to provoke
inflammation even when injected directly into tissues.
The ICG dye was first developed in the mid-1950s to determine
cardiac output and hepatic function. The dye is rapidly cleared, low in
toxicity and well tolerated by subjects, even at doses that exceed what
is now routinely given by tenfold (Miller et al., 1962; Wood, 1962).
This has led to its application to a variety of clinical uses, with
examples including sentinel nodebiopsy, tumour demarcation surgery
and lymphatic vessel assessment. The main advantage of ICG is its
track record of safety and tolerance, more than 60 years of application
in clinical practice, and the ability of an NIR dye to be visualized
without the need for tissue windows, i.e. for non-invasive imaging.
Techniques for in vivo cellular imaging require a biocompatible,
non-toxic agent that allows reproducible quantification of these
infiltrating leukocytes. Alternative methods that have been
described for in vivo imaging are dyes which are conjugated to
antibodies, allowing more specificity of binding or ex-vivo labelling
(labelling cells outside the circulation and reintroduction into the
circulation). Our results clearly demonstrate that this simple method
of using ICG as a depot injection to label cells in vivo can be
achieved in mouse models. Translation of this insight into the clinic
will involve the development of a formulation suitable for depot
ICG application in humans. This might be useful not only for
monitoring ocular inflammation but might also have applications
further afield, for example, the detection of an immune response to
new treatment strategies, such as stem cell therapies or retinal
implants, or serve as an imaging biomarker for predicting the onset
of angiogenesis in age-related macular degeneration or diabetic
retinopathy.
MATERIALS AND METHODS
In vitro labelling of peripheral blood mononuclear cells and
splenocytes with ICG
Mouse blood was drawn via cardiac puncture with a 0.5 M EDTA-coated
23-gauge needle, before either red cell lysis or Ficoll-gradient separation
using Histopaque-1077 (Sigma-Aldrich, UK) according to the
manufacturer’s guidelines. Cells were stained with ICG, then incubated
with Fc-block (BDBiosciences, UK) before primary antibody staining at the
manufacturer’s recommended concentrations at 4°C for 20 min. All
antibodies were from BD Biosciences.
Fig. 4. In vivo labelling of infiltrating leukocytes in a laser-induced choroidal neovascularization (CNV) murine model. The scanning laser
ophthalmoscope with a near-infrared filter (790-nm diode excitation laser and 800-nm long-pass filter) was used to image the retina and choroid. (A) A deep
retinal/choroidal image of a control animal that did not receive an i.p. injection of ICG. No fluorescence was detected using the near-infrared filter. (B) A deep
retinal/choroidal image of an animal that did receive i.p. ICG and laser induction of CNV, showing fluorescence in the retinal vessels and laser lesions. No obvious
leakage of ICG could be seen in the surrounding retinal tissues. (C) A deep retinal/choroidal image of an animal that received i.p. ICG (10 days before imaging)
and laser induction of CNV (7 days before imaging), showing an accumulation of ICG-labelled cells in and around the laser lesions. (C′) Magnified image of laser
lesion and surrounding cells. (D) A deep retinal/choroidal image of the same animal shown in C 3 days later (13 days after i.p. ICG), showing that the intensity of
the ICG signal has reduced. (D′) Magnified image of laser lesion and surrounding cells. (E) A deep retinal/choroidal image of an animal that received i.p. ICG
(10 days before imaging) with six laser-induced CNV lesions (7 days before imaging), showing accumulation of ICG-labelled cells in and around all six laser
lesions. (F,G) Corresponding fluorescein angiography images of the superficial retina and deep retina/choroid obtained 10 min after i.p. injection with 100 µl of
fluorescein dye and imaged with a blue-light filter (488-nm solid-state excitation laser and 500-nm long-pass filter). (G) Deep retinal/choroidal images show that
only two of six laser lesions subsequently developed choroidal neovascularization, and none of these 1-week-old lesions showed obvious fluorescein dye
leakage into the surrounding tissues, suggesting that inflammatory cellular infiltration occurred independently of vascular leakage.
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Human PBMCs were isolated from 20 ml of whole blood using a Ficoll
gradient.
PBMCs were isolated from murine whole blood using Percoll-gradient
separation, and splenocytes were mechanically dissociated before being
incubated in 6.25 µg/ml ICG for 30 min at room temperature. PBMCs and
splenocytes were washed and co-stained with CD45, CD11b and CD3
fluorescent antibodies (Miltenyi Biotech, Bisley, UK).
Flow cytometric analysis of ICG-labelled cells
ICG-stained PBMCs, whole blood and splenocytes were analysed using a BD
Bioscience LSRII flow cytometer because no commercial machine was
available with a near-infrared laser for ideal excitation of ICG. Suboptimal
excitation by the 633 nm red laser nonetheless resulted in a reliable signal
using a 780/60 bandpass filter. Aminimum of 10,000 events was collected for
each sample, and fluorescence-minus-one controls were used to determine the
placement of gates. Data were processed using FlowJo v10.1 (TreeStar,
Ashton, OR, USA). For the toxicity assessment, gating on the following
populations was performed (after exclusion of debris and cellular aggregates):
lymphocytes (CD4+/CD8+/B220+); total myeloid populations (CD11b+);
neutrophils (Ly6G+); natural killer cells (NK1.1+); dendritic cells (CD11chigh);
and monocytes/macrophages (CD11b+/CD11clow/Ly6G–/NK1.1+). Cell
death within each population was then analysed using a live:dead stain.
Generation of bone-marrow-derived macrophages
Generation of bone-marrow-derived macrophages (BMDMs) followed the
protocol from the original report (Munder et al., 1999). In brief, mouse
femurs and tibias were collected and bone marrow cells were flushed out,
followed by 8 days of maturation in Teflon bags with Dulbecco’s modified
Eagle’s medium containing 10% heat-inactivated fetal calf serum, 5%
normal horse serum, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 U/ml
penicillin-streptomycin, 50 mM 2-mercaptoethanol (all from Life
Technologies) and 100 pg/ml colony-stimulating factor 1 generated from
L929 fibroblast-conditioned media.
Mouse interleukin-6 ELISA
BMDMs were plated at a density of 5×105 cells/well in a 96-well flat-
bottomed plate. Four hours later, the medium was exchanged for 0.2 mg/ml
ICG dye, with either medium alone or 5 ng/ml LPS. After the indicated
times, supernatants were collected and frozen at −80°C. Mouse IL-6
sandwich ELISA was performed in technical triplicate according to the
manufacturer’s instructions (BD Biosciences, UK) using rat anti-mouse IL-
6, 554400 and biotin rat anti-mouse IL-6, 554402.
Spectrophotometry of ICG
BMDMs were plated in flat-bottomed 96-well plates for 4 h in 10% fetal calf
serum and Dulbecco’s modified Eagle’s medium, before the addition of ICG
to a concentration of 0.2 mg/ml. Cellswere incubated for the specified amount
of time before washing five times with PBS. After this, 200 μl of PBS was
added to the well for 5 min and then removed for spectrophotometry. Triton
(2%) in 200 μl PBS was then added to each well and the supernatant also
removed after 5 min. Spectrophotometry was performed using a SpectraMax
190 (Molecular Devices, Wokingham, UK), with SoftMax Pro (v6.0)
software, set to an absorbance of 790 nm.
Bright-field microscopy
BMDMs were imaged in flat-bottomed 96-well plates with a Leica DMIRB
microscope using Leica QFluoro software v3.1. No filters were used, but
light intensity was adjusted.
Fig. 5. In vivoquantification of laser-inducedCNV-related infiltration. (A) ICGwas injected i.p. at day 0 before laser induction of CNVat day 3 inC57BL/6mice.
Imaging with the scanning laser ophthalmoscope using a near-infrared filter (790-nm diode excitation laser and 800-nm barrier filter) was performed on days 5, 7
and 10. (C-E) Increasing cellular infiltration in and surrounding the laser-CNV lesion was observed over time. (B,C′-E′) We demonstrate that the mean intensity
values and standard deviations can be quantified over a given area and showan increase in inflammation over time. Themean intensity value of the lesion at day 5
is represented by the black histogram (C′), day 7 the superimposed light grey histogram (D′) and day 10 the superimposed medium grey histogram (E′).
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Magnetic-activated cell sorted separation of CD4+ cells
Single-cell spleen suspensions from C57BL/6 mice were erythrocyte lysed
by ammonium-calcium-potassium (ACK) buffer. Splenic CD4 cells were
prepared by enriching CD4+ cells using anti-CD4 microbeads (Miltenyi
Biotech, UK) according to the manufacturer’s instructions.
Animals
All animals were handled in accordance with the UK Animals (Scientific
Procedures) Act 1986. Female C57BL/6J mice (Harlan, UK) at 7-8 weeks
of age were used. For in vivo procedures, the mice were anaesthetized with
an i.p. injection of medetomindine hydrochloride (1 mg/kg body weight;
Domitor; Pfizer Animal Health, New York, NY, USA) and ketamine
(60 mg/kg body weight) in water. Pupillary dilatation was achieved with one
drop of 1% Tropicamide (Bausch and Lomb, Kingston-upon-Thames, UK).
Induction of endotoxin-induced uveitis
Female C57BL/6J mice (Harlan, UK) at 8 weeks of age received a single
i.p. injection of 0.2 mg of LPS from E. coli (Sigma-Aldrich, St Louis,
MO, USA) in PBS. A 1 mg i.p. bolus injection of ICG was given 24 h
before the LPS treatment. Imaging was performed 48 h later, at a
previously determined time point when there is peak infiltration by
myeloid cells.
Induction of experimental autoimmune uveoretinitis
Female C57BL/6J mice (Harlan, UK) at 7 weeks of age received 500 μg of
human RBP-1-20 peptide subcutaneously, emulsified in complete
Freund’s adjuvant (Sigma-Aldrich, UK) supplemented with 1.5 mg/ml
Mycobacterium tuberculosis H37RA (Difco Laboratories, BD, Oxford,
UK). Pertussis toxin (1.5 μg) was simultaneously administered into the
peritoneal space (Tocris Bioscience, Bristol, UK). Imaging was performed
26 days later at the time point determined to be the disease peak in our
facility using this protocol.
Induction of laser choroidal neovascularization
In female C57BL/6J mice (Harlan, UK) at 7-8 weeks of age, laser CNVwas
induced using a slit-lamp-mounted diode laser system (wavelength 680 nm;
Keeler, Windsor, UK). The laser settings used were as follows: 200 mW
power, 100 ms duration and 100 µm spot diameter. Laser CNV lesions were
applied at a distance of three disc diameters from the optic nerve, avoiding
any blood vessels.
In vivo imaging
Ocular imaging was performed using a scanning laser ophthalmoscope
(Spectralis™HRA; Heidelberg Engineering, Heidelberg, Germany). A lens
with a 55° field of viewwas used, and amean of 100 consecutive frames was
taken for each image. In order to visualize ICG-labelled cells, a near-infrared
filter (790 nm diode excitation laser and 800 nm long-pass filter) was used.
Cell labelling was achieved with various doses (from 1 to 0.0125 mg;
Fig. S4) of 5 mg ICG (Pulsion Medical Systems AG) dissolved in 5 ml of
water and administered 3 days before laser induction of CNV, i.p. injection
of LPS or imaging of the experimental autoimmune uveoretinitis model.
The different routes of administration are summarized in Fig. S5. To assist
the identification of laser CNV lesions, infrared-reflectance imaging was
performed with an 820 diode excitation laser and no barrier filter. For
autofluorescence imaging and fluorescein angiography, a blue-light filter
(488 nm solid-state excitation laser and 500 nm long-pass filter) was used.
Fluorescein angiography was performed 1 week after laser CNV induction
with an i.p. injection of 0.2 ml fluorescein sodium (2%). Images were
acquired at 90 s and 7 min after injection.
Quantification of ICG+ cells in the retina
Images were exported from the Heidelberg eye explorer version 1.7.1.0 and
processed in Adobe Photoshop CS5 (Adobe Systems, San Jose, CA, USA).
Details of image processing and quantification can be found in the Results
section and Fig. S5.
Fig. 6. Characterization of in vivo ICG-labelled cells in a laser-inducedCNVmurinemodel. The animal was injected i.p. with ICG 10 days before imaging and
laser CNV induced 7 days before imaging. Fifty microlitres of a CD11b antibody conjugated to fluorescein isothiocyanate (FITC) was injected into the tail vein
before being imaged at 15 and 30 min post-injection to assess the identity of ICG-labelled cells. A blue-light filter (488-nm solid-state excitation laser and 500-nm
barrier filter) was used for the detection of cell labelling by CD11b-FITC. A scanning laser ophthalmoscope was used to acquire all images. (A) An infrared-
reflectance (IR) image (820-diode excitation laser, no barrier filter) demonstrating the presence of laser-induced CNV lesions in the deep retina/choroid. (B) A
deep retinal/choroidal image obtained with a near-infrared filter (790-nm diode excitation laser and 800-nm barrier filter), showing ICG-labelled cells surrounding
two laser-induced CNV lesions. (C) A magnified view of ICG-labelled cells surrounding the CNV lesion from the top lesion in (B). (D,E) A deep retinal/choroidal
image of the same mouse shown in (B) at 15 min (D) and 30 min (E) after a tail vein injection of CD11b-FITC. (F) A magnified view of CD11b-FITC-labelled cells
surrounding the CNV lesion from (E), showing co-labelling of most but not all ICG-labelled cells.
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